5353 Delveinsight 1

Schizophrenia-Epidemiology-Forecast

DelveInsight’s ‘Schizophrenia Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Schizophrenia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

The epidemiology report gives a thorough understanding of the disease symptoms and causes, as well as the risk factors, diagnosis, pathophysiology associated with the disease, and treatment guidelines for Schizophrenia in 7MM. The report provides epidemiology of Schizophrenia segmented by total diagnosed incident cases, age, gender, type-specific diagnosed incident cases, diagnosed incident population-based on primary site of Schizophrenia, and diagnosed incident population based on the histologic classification of Schizophrenia.

Request for Sample @ Schizophrenia Epidemiology Report

Key Highlights of the Schizophrenia Epidemiology Report

  • As per DelveInsight, the total Schizophrenia prevalent population in the 7MM was 5,748,062 in 2020. These cases of schizophrenia in the 7MM are expected to increase throughout the study period, i.e., 2018–2030.
  • Among the European five countries, Germany has the highest diagnosed prevalent population followed by the United Kingdom and France. On the other hand, Spain had the lowest diagnosed prevalent population.
  • According to DelveInsight, males are more affected with Schizophrenia as compared to females in the US and EU-5. But in Japan, females have higher diagnosed cases.
  • Currently, with certain medication, psychosocial rehabilitation, and family support, the symptoms of schizophrenia can be reduced. Medications help in relieving symptoms of psychosis, such as delusions and hallucinations. 
  • Lack of awareness of the disease is one of the major challenges in the management of Schizophrenia, similarly, it is observed that the expected serious side effects of medication that have been prescribed to treat schizophrenia, often make people hesitant to take them.

Visit to get a more detailed insight into the patient pool @ Schizophrenia Epidemiology and Patient Population

Schizophrenia Disease Overview 

Schizophrenia is a chronic brain disorder that interferes with a person’s thinking ability, management of emotions, and decision making. It is a serious medical illness that often results in delusions, hallucinations, disorganized speech, and lack of motivation. People affected with Schizophrenia may experience symptoms differently.

It is observed that genetics and environment influence the occurrence of Schizophrenia. In the United States, less than one percent of the population is affected by it. As per the National Alliance on Mental Illness (NAMI), “schizophrenia can occur at any age, the average age of onset tends to be in the late teens to the early 20s for men, and the late 20s to early 30s for women”.

Dive deeper to know more @ Schizophrenia Disease Background and Overview

Schizophrenia Epidemiology Segmentation – 

  • Prevalent Cases of schizophrenia
  • Diagnosed Prevalent cases of schizophrenia
  • Age-specific Diagnosed Prevalent cases of schizophrenia
  • Gender-specific Diagnosed Prevalent cases of schizophrenia
  • Severity-specific Diagnosed Prevalent cases of schizophrenia

 Check out for more @ Schizophrenia Prevalent and Diagnosed Cases 

Scope of the Report

  • Detailed segmentation of the Schizophrenia epidemiology. 
  • A historical and forecasted patient pool of Schizophrenia in 7MM.
  • Assessment of the growth opportunities in the 7MM with respect to the Schizophrenia patient population.
  • Detailed analysis of Schizophrenia symptoms, causes, diagnosis, classification, pathophysiology, and its treatment patterns.
  • A comprehensive evaluation of the disease in terms of its burden, and the unmet needs.
  • Overview of the risk factors and trends of Schizophrenia in 7MM.

Got queries? Reach out for more information @ Schizophrenia Market Research Report 

Table of Contents –

1 Key Insights 
2 Report Introduction
3 Schizophrenia: Overview at a Glance
4 Disease Background and Overview: Schizophrenia
5 Schizophrenia: Epidemiology and Patient Population
6 KOL Views
7 Appendix
8 DelveInsight Capabilities
9 Disclaimer
10 About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

Key Highlight of the Reports – 

  • Geographies Covered
    • The United States
    • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
    • Japan
  • Study Period: 2018–2030 
  • Key Assessments 
    • Patient Segmentation
    • Disease Risk and Burden
    • Risk of disease by the segmentation
    • Factors driving growth in a specific patient population

Related Reports

DelveInsight’s “Schizophrenia Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Schizophrenia market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Schizophrenia Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Schizophrenia market.

DelveInsight’s “Corneal Endothelial Dystrophy Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Corneal Endothelial Dystrophy market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

DelveInsight’s, “Electroencephelographs (EEG) Pipeline Insight and Competitive Landscape, 2020,” report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Electroencephelographs pipeline landscape. The report provides a detailed study of the emerging Electroencephelographs devices along with competitive landscape to help better understand the emerging Electroencephelographs devices and also covers the present clinical development scenario and growth prospects across Electroencephelographs (EEG) market. 

DelveInsight’s “Lymphatic Malformations Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Lymphatic Malformations market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

DelveInsight’s, “Bevacizumab– Biosimilar Insight, 2020,” report provides comprehensive insights about 40+ companies and 40+ marketed and pipeline drugs in Bevacizumab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. 

DelveInsight’s “Acute Pyelonephritis Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Acute Pyelonephritis market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Healthcare Blogs – 

Get in touch with our Business executive for Competitive Intelligence Services

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect With Us at LinkedIn | Facebook | Twitter

Tags: Schizophrenia Pipeline, Schizophrenia Epidemiology, Schizophrenia, Schizophrenia Market

Contact Information:

Shruti Thakur  [email protected]  +91-9650213330